Likewise, the attempt to correlate glioma survival with survivin expression by IHC led to inconsistent results, possibly due to the heterogeneity of cut-offs and analysis methods applied to categorize survivin levels in glioma patients [64]. This evidence concerns the gene BIRC5 and central nervous system cancer.